Search

everythinglearnresearchcommunity

for

Search:↓

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

New medications could improve treatment for severe alopecia areata in Australia.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Telogen effluvium is hair loss caused by many hairs stopping growth suddenly, often due to stress or illness, but sometimes it's normal and not due to disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Nails can reveal important health information about skin and body conditions.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Covid-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Men with severe androgenetic alopecia, especially on the top of the head, have a higher risk of coronary artery disease.

SLE and DM can coexist but are rare and need careful evaluation.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Nonbullous impetigo is the most common bacterial skin infection in children, often needing treatment to prevent complications.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

A woman with lupus and severe nerve damage improved with specific treatments.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Poor body image from pain can lead to more depression in lupus patients.